Workflow
Medicare Fraud
icon
搜索文档
UnitedHealth stock drops 17% after report it is being probed by DOJ for alleged Medicare fraud
New York Post· 2025-05-15 23:26
UnitedHealth Group’s stock plunged Thursday morning after a report that the embattled insurance giant was being probed for Medicare fraud.The Department of Justice has been conducting the criminal investigation into whether the company — which pushed out CEO Andrew Witty on Monday — manipulated Medicare Advantage billing practices to improperly increase federal payments by inflating patient risk scores, the Wall Street Journal reported on WednesdayThe existence of the probe, which began last year but had no ...
UnitedHealth Group shares drop 16.5% after inquiry into alleged Medicare fraud
The Guardian· 2025-05-15 23:15
公司动态 - 美国最大健康保险公司UnitedHealth Group因涉嫌刑事医疗保险欺诈被调查 股价在纽约早盘交易中暴跌16.5% 今年以来股价已腰斩 [1] - 公司CEO Andrew Witty因个人原因辞职 同时暂停全年财务展望 原因是医疗成本高于预期 [2] - 公司高管Brian Thompson于12月在纽约一家酒店外被袭击身亡 [2] 调查事件 - 美国司法部自去年夏天开始对UnitedHealth进行刑事调查 涉及Medicare Advantage项目 [1][3] - 华尔街日报报道称公司面临民事欺诈调查 参议员Chuck Grassley也对公司账单方式展开调查 [4] - 公司否认收到司法部通知 坚称Medicare Advantage项目诚信可靠 [3] 业务背景 - Medicare是美国政府为老年人和残疾人提供的医疗保险计划 Medicare Advantage是私营保险公司与Medicare签约提供健康福利的项目 [3] - 公司数十年来通过保险领域主导地位和在Medicare市场的增长而蓬勃发展 [5]
UnitedHealth Group shares plunge 18% on reported DOJ probe into possible Medicare fraud
CNBC· 2025-05-15 22:55
Shares of UnitedHealth Group plunged more than 18% on Thursday following a report that the Justice Department is conducting a criminal investigation into the health-care giant over possible Medicare fraud.The DOJ is focusing on the company's Medicare Advantage business practices, but the exact nature of the potential criminal allegations is unclear, the Wall Street Journal reported late Wednesday, citing people familiar with the matter. In a statement, UnitedHealth Group said the Justice Department has not ...
UnitedHealth shares slide as criminal probe report adds to investor fears
Fox Business· 2025-05-15 22:16
UnitedHealth Group shares fell more than 15% in early morning trading on Thursday, after The Wall Street Journal reported that the U.S. Department of Justice was investigating the company for potential Medicare fraud. The latest news adds to the health insurer's litany of woes, including multiple government inquiries, a sudden change in top leadership and a pulled outlook in the face of soaring medical costs.Investors and analysts noted that while details on the investigation were limited, they did heighten ...